Prolonged therapy of chronic hepatitis C with ribavirin

Journal of Viral Hepatitis

Volumn 3, Issue 5, 1996, Pages 247-252

  Hoofnagle, J H ^a,d   Lau, D ^a   Conjeevaram, H ^a   Kleiner, D ^b   Di Bisceglie, A M ^a,c  

^a NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES   (United States)

^b NATIONAL CANCER INSTITUTE   (United States)

^c SAINT LOUIS UNIVERSITY SCHOOL OF MEDICINE   (United States)

^d NATIONAL INSTITUTES OF HEALTH   (United States)

Author keywords

Antivirals; Chronic hepatitis; Gallstones; Haemolysis; Hepatitis C virus; Nucleoside analogue

Indexed keywords

ALANINE AMINOTRANSFERASE; ANTIVIRUS AGENT; RIBAVIRIN; VIRUS RNA;

ADULT; ARTICLE; BILE DUCT DISEASE; BIOPSY; BLOOD; CHOLELITHIASIS; CLINICAL TRIAL; FATIGUE; FEMALE; GENETICS; HEADACHE; HEMATOCRIT; HEPATITIS C; HEPATITIS C VIRUS; HUMAN; LIVER; MALE; MIDDLE AGED; PATHOLOGY; VIROLOGY;

ADULT; ALANINE TRANSAMINASE; ANTIVIRAL AGENTS; BILE DUCT DISEASES; BIOPSY; CHOLELITHIASIS; FATIGUE; FEMALE; HEADACHE; HEMATOCRIT; HEPACIVIRUS; HEPATITIS C; HUMANS; LIVER; MALE; MIDDLE AGED; RIBAVIRIN; RNA, VIRAL;

EID: 0030227143     PISSN: 13520504     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1365-2893.1996.tb00050.x     Document Type: Article

References (20)

1. Gilbert BE, Knight V. Biochemistry and clinical applications of ribavirin. Antimicrob Agents Chemother 1986; 30: 201-205.
2. Hall CB, Walsh EE, Hruska JF, Betts RF, Hall WJ. Ribavirin treatment of experimental respiratory syncytial viral infection. A randomized controlled double-blind study in young adults. JAMA 1983; 249: 2666-2670.
3. Lertora JJL, Rege AB, Lacour JT et al. Pharmacokinetics and tolerance to ribavirin in asymptomatic patients with human immunodeficiency virus. Clin Pharmacol Ther 1991; 50: 442-449.
4. Reichard O, Andersson J, Schvarcq R, Weiland O. Ribavirin treatment for chronic hepatitis C. Lancet 1991; 337: 1058-1061.
5. Di Bisceglie AM, Shindo M. Fong T-L et al. A pilot study of ribavirin therapy for chronic hepatitis C. Hepatology 1992; 16: 649-654.
6. Camps J, Garcia N, Riezu-Boj JI, Civeira MP, Prieto J. Ribavirin in the treatment of chronic hepatitis C unresponsive to alfa interferon. J Hepatol 1993; 19: 408-412.
7. Di Bisceglie AM, Fried MV, Swain MG et al. Ribavirin as therapy for chronic hepatitis C. A randomized, double-blind placebo-controlled trial. Ann Intern Med 1995; 123: 897-903.
8. Dushieko G, Weiland O, Thomas H et al. Results of a placebo-controlled study of ribavirin in patients with chronic hepatitis C. Hepatology 1994; 20: 206A (abstract).
9. Bodenheimer HC, Lindsay KL, Davis GL et al. Tolerance and efficacy of oral ribavirin treatment of chronic hepatitis C: a multicenter trial. Hepatology 1994; 20: 207A (abstract).
10. Johnson PJ, McFarlane IG, Williams R. Azathioprine for long-term maintenance of remission in autoimmune hepatitis. N Engl J Med 1995; 333: 958-963.
11. Combes B, Carithers RL Jr, Maddrey WC et al. A randomized, double-blind, placebo-controlled trial of ursodeoxycholic acid in primary biliary cirrhosis. Hepatology 1995; 22: 759-766.
12. Di Bisceglie AM, Martin P, Kassianides C et al. Recombinant interferon alfa therapy for chronic hepatitis C. A randomized, double-blind, placebo-controlled trial. N Engl J Med 1989; 321: 1506-1510.
13. Shindo M, Di Biscelgie AM, Cheung L et al. Decrease in hepatitis C viral RNA during alpha-interferon therapy for chronic hepatitis C. Ann Intern Med 1990; 115: 700-704.
14. Lau JYN, Davis GL, Kniffen J et al. Significance of serum hepatitis C virus RNA levels in chronic hepatitis C. Lancet 1993; 341: 1501-1504.
15. Desmet V, Gerber M, Hoofnagle JH, Manns M, Scheuer P. Classification of chronic hepatitis: Diagnosis, grading and staging. Hepatology 1994; 19: 1513-1520.
16. Di Bisceglie AM, Bacon BR, Kleiner DE, Hoofnagle JH. Increase in hepatic iron stores following prolonged therapy with ribavirin in patients with chronic hepatitis. J Hepatol 1994; 21: 1109-1112.
17. Hoofnagle JH. Therapy of acute and chronic hepatitis. Adv Intern Med 1994; 39: 241-275.
18. Brillanti S, Garson J, Foli M et al. A pilot study of combination therapy with ribavirin plus interferon alfa for interferon-alfa resistant chronic hepatitis C. Gastroenterology 1994; 107: 812-817.
19. Chemello L, Cavalletto L, Bernardinello E et al. Response to ribavirin, to interferon and to a combination of both in patients with chronic hepatitis C and its relation to HCV genotypes. J Hepatol 1994; 21(Suppl 1): S12 (abstract).
20. Lai MY, Yang PM, Kao JH et al. Combination therapy of interferon-α and ribavirin in patients with chronic hepatitis C: an interim report. Hepatology 1993; 18: 93A (abstract).